We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.11 | 0.14 | 0.125 | 0.125 | 0.125 | 2,100,000 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 1.78M | -1.28M | -0.0007 | -1.71 | 2.22M |
TIDMDEMG
RNS Number : 2057A
Deltex Medical Group PLC
18 January 2024
18 January 2024
Deltex Medical Group plc
("Deltex Medical", the "Company" or the "Group")
Issue of equity to satisfy equity-settled non-executive directors' fees
The Board of Deltex Medical (AIM: DEMG), announces the issue of 49,372,352 new ordinary shares of 1p each in the capital of the Company (the "Ordinary Shares"), at an issue price of 0.17 pence per new Ordinary Share (the "Issue Price"). The Issue Price represents the Company's closing mid-market price on 17 January 2024.
The new Ordinary Shares are being issued in order to satisfy the fees of certain current and former non-executive directors for the year ending 31 December 2023 ("Fee Shares"), as has been done in previous years.
A total of 12,941,176 Fee Shares will be issued to former non-executive director Mark Wippell and a total of36,431,176 Fee Shares will be issued to current non-executive directors as set out below:
Resultant holding post Fee Shares Director Current Fee Shares Ordinary As a percentage Ordinary issued Shares held of the enlarged Shares held share capital on Admission Nigel Keen 332,267,649 22,313,529 354,581,178 18.70% Chris Jones 6,479,109 14,117,647 20,596,756 1.09%
Under the contract with Nigel Keen, he or the Company can opt to settle his fees (plus employer's national insurance) by the issue of new ordinary shares at the share price at the time of issue and the same applies to Chris Jones' and Ben Carswell's contracts for up to half of their fees. These share issues are expected to occur on an annual basis when permitted.
Application for admission to trading and total voting rights
Application has been made for 49,372,352 new Ordinary Shares to be admitted to trading on AIM, which is expected to take effect on or around 24 January 2024 ("Admission").
Following Admission, the Company's issued share capital will comprise 1,896,025,700 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For further information, please contact:
Deltex Medical Group plc 01243 774 837 Nigel Keen, Chairman investorinfo@Deltexmedical.com Andy Mears, Chief Executive Natalie Wettler, Group Finance Director Nominated Adviser and Broker Allenby Capital Limited 020 3328 5656 Jeremy Porter / Vivek Bhardwaj (Corporate info@allenbycapital.com Finance) Tony Quirke / Stefano Aquilino (Sales & Corporate Broking)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
1. Details of the person discharging managerial responsibilities / person closely associated a) Name PDMRs: Nigel Keen Non-Executive Director - Chairman Chris Jones Non-Executive Director ----------------------- -------------------------------- -------------------------------------------- 2. Reason for the Notification ------------------------------------------------------------------------------ a) Position/status See 1a) above -------------------------------- -------------------------------------------- b) Initial notification/Amendment Initial Notification -------------------------------- -------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------ a) Name Deltex Medical Group Plc -------------------------------- -------------------------------------------- b) LEI 213800XN34P6LI8J6M39 -------------------------------- -------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------ a) Description of Ordinary shares of 0.1p each in the Financial Deltex Medical Group Plc instrument, type of instrument -------------------------------- -------------------------------------------- Identification ISIN: GB0059337583 code -------------------------------- -------------------------------------------- b) Nature of the Fee shares transaction -------------------------------- -------------------------------------------- c) Price(s) and volume(s) Name Price(s) Volume(s) Nigel Keen 0.17p 22,313,529 --------- ----------- Chris Jones 0.17p 14,117,647 --------- ----------- -------------------------------- -------------------------------------------- d) Aggregated information: -------------------------------- -------------------------------------------- * Aggregated volume 36,431,176 ------------------------------------- -------------------------------------------- * Price 0.17p ------------------------------------- -------------------------------------------- e) Date of the transaction 18 January 2024 -------------------------------- -------------------------------------------- f) Place of the transaction Outside a trading venue -------------------------------- --------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOESFUFMAELSEIF
(END) Dow Jones Newswires
January 18, 2024 12:01 ET (17:01 GMT)
1 Year Deltex Medical Chart |
1 Month Deltex Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions